HIV and HTLV-1 coinfection: the need to initiate antiretroviral therapy

E Ticona, MA Huaman, O Yanque… - Journal of the …, 2013 - journals.sagepub.com
According to the latest Department of Health and Human Services guidelines for the use of
antiretroviral therapy (ART) in HIV-1-infected persons, initiation of ART is recommended for …

HTLV-II/HIV-1 coinfection and risk for progression to AIDS among intravenous drug users

A Visconti, L Visconti, R Bellocco, N Binkin… - JAIDS Journal of …, 1993 - journals.lww.com
To determine whether coinfection with HTLV-II influences the course of HIV-1 infection, we
evaluated the progression from asymptomatic HIV infection (CDC group II) to persistent …

HTLV-II down-regulates HIV-1 replication in IL-2–stimulated primary PBMC of coinfected individuals through expression of MIP-1α

C Casoli, E Vicenzi, A Cimarelli… - Blood, The Journal …, 2000 - ashpublications.org
The influence of human T-cell leukemia/lymphoma virus type II (HTLV-II) in individuals also
infected with HIV-1 is poorly understood. To evaluate the reciprocal influence of HTLV-II and …

HTLV-I coinfection in a HIV-1-infected Peruvian population

I Phillips, KC Hyams, FS Wignall, AY Moran… - J Acquir Immune Defic …, 1991 - apps.dtic.mil
HTLV-1 Coinfection in a HIV-1-Infected Peruvian Population Page 1 AD-A234 211 REPORT
DOCUMENTATION PAGE lb. RESTRICTIVE MARKINGS IINCI 2a. SECURITY …

Prevalences of HTLV-1 infection and associated risk determinants in an urban population in Guinea-Bissau, West Africa

O Larsen, S Andersson, Z da Silva… - JAIDS Journal of …, 2000 - journals.lww.com
Objective: To assess the prevalence and modes of transmission of HTLV-1 infection in an
adult population in Bissau, and to evaluate possible interactions between the pattern of …

Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2

MA Beilke, KP Theall, JL Clayton… - Clinical Infectious …, 2004 - academic.oup.com
The goal of this study was to investigate clinical outcomes and survival probabilities among
persons coinfected with human immunodeficiency virus (HIV) and human T lymphotropic …

Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo

LH Harrison, TC Quinn… - Journal of Infectious …, 1997 - academic.oup.com
Human T lymphotropic virus type I (HTLV-I) can increase human immunodeficiency virus
(HIV) replication in vitro, and several studies suggest that HTLV-I accelerates the …

HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users

JB Page, S Lai, DD Chitwood, NG Klimas, PC Smith… - The Lancet, 1990 - Elsevier
In a prospective study of street-recruited intravenous drug users (IVDUs) in Miami, Florida,
USA, 107 (46· 5%) of 230 IVDUs were infected with HIV-1. Of these HIV-1 seropositive …

Pathways of cell-cell transmission of HTLV-1

C Pique, KS Jones - Frontiers in microbiology, 2012 - frontiersin.org
The deltaretroviruses human T cell lymphotropic virus type 1 (HTLV-1) and human T cell
lymphotropic virus type 2 (HTLV-2) have long been believed to differ from retroviruses in …

HTLV-2b among HIV type 1-coinfected injecting drug users in Spain

M Abad, F Dronda, E Dominguez… - AIDS research and …, 2011 - liebertpub.com
Human T cell lymphotropic virus type 2 (HTLV-2) infection is endemic in the American Indian
population and Pygmy tribes in Africa. Nevertheless, HTLV-2 infection has been …